Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT)

Biomaterials

Volumn 37, Issue , 2015, Pages 415-424

  Beziere, Nicolas ^a   Lozano, Neus ^b,c   Nunes, Antonio ^a   Salichs, Juan ^a   Queiros, Daniel ^a   Kostarelos, Kostas ^b,c   Ntziachristos, Vasilis ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Imaging; Indocyanine green; Liposome; Optoacoustic; Photoacoustic; Tumor

Indexed keywords

FIBER OPTIC SENSORS; IMAGING TECHNIQUES; LIPOSOMES; METAL NANOPARTICLES; NANORODS; OPTICAL IMAGE STORAGE; PHOTOACOUSTIC EFFECT; TOMOGRAPHY; TUMORS;

HIGH-RESOLUTION IMAGING; INDOCYANINE GREEN; METALLIC NANOPARTICLES; OPTOACOUSTIC TOMOGRAPHY; PEGYLATED LIPOSOMES; SPATIO TEMPORAL FEATURES; TISSUE ACCUMULATION; TUMOR MICROENVIRONMENT;

GOLD NANOPARTICLES;

CONTRAST MEDIUM; GOLD NANOPARTICLE; INDOCYANINE GREEN; LIPOSOME; MACROGOL; PEGYLATED LIPOSOME INDOCYANINE GREEN; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; IN VIVO STUDY; MOUSE; MULTISPECTRAL PHOTOACOUSTIC TOMOGRAPHY; NONHUMAN; PHOTOACOUSTIC TOMOGRAPHY; PHOTOACOUSTICS; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SENSITIVITY ANALYSIS; SPATIOTEMPORAL ANALYSIS; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; FLUORESCENCE; KINETICS; NEAR INFRARED SPECTROSCOPY; PROCEDURES; TOMOGRAPHY; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; FLUORESCENCE; HUMANS; INDOCYANINE GREEN; KINETICS; LIPOSOMES; MICE; PHOTOACOUSTIC TECHNIQUES; POLYETHYLENE GLYCOLS; SPECTROSCOPY, NEAR-INFRARED; TISSUE DISTRIBUTION; TOMOGRAPHY; TUMOR MICROENVIRONMENT;

EID: 84922248908     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.10.014     Document Type: Article

References (45)

1. Bangham A.D., Horne R.W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. JMol Biol 1964 May, 8:660-668.
2. Al-Jamal W.T., Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Accounts Chem Res 2011 Oct 18, 44(10):1094-1104.
3. Sawant R.R., Torchilin V.P. Liposomes as 'smart' pharmaceutical nanocarriers. Soft Matter 2010, 6(17):4026-4044.
4. Schwendener R.A., Schott H. Liposome formulations of hydrophobic drugs. Methods Mol Biol 2010, 605:129-138. PubMed PMID: 20072877. Epub 2010/01/15. eng.
5. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994 Feb 15, 54(4):987-992.
6. Minisini A.M., Andreetta C., Fasola G., Puglisi F. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer. Expert Rev Anticancer Ther 2008 Mar, 8(3):331-342.
7. Tejada-Berges T., Granai C.O., Gordinier M., Gajewski W. Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer. Expert Rev Anticancer Ther 2002 Apr, 2(2):143-150.
8. Iyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006, 11(17-18):812-818.
9. Luk B.T., Fang R.H., Zhang L. Lipid- and polymer-based nanostructures for cancer theranostics. Theranostics 2012, 2(12):1117-1126. PubMed PMID: 23382770.
10. Strijkers G.J., Kluza E., Van Tilborg G.A., van der Schaft D.W., Griffioen A.W., Mulder W.J., et al. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis 2010 Jun, 13(2):161-173.
11. Petersen A.L., Hansen A.E., Gabizon A., Andresen T.L. Liposome imaging agents in personalized medicine. Adv Drug Deliv Rev 2012, 64(13):1417-1435.
12. Rubesova E., Berger F., Wendland M.F., Hong K., Stevens K.J., Gooding C.A., et al. Gd-labeled liposomes for monitoring liposome-encapsulated chemotherapy: quantification of regional uptake in tumor and effect on drug delivery. Acad Radiol 2002 Aug, 9(Suppl.2):S525-S527.
13. Viglianti B.L., Abraham S.A., Michelich C.R., Yarmolenko P.S., MacFall J.R., Bally M.B., et al. Invivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med 2004 Jun, 51(6):1153-1162.
14. Badea C.T., Athreya K.K., Espinosa G., Clark D., Ghafoori A.P., Li Y.F., et al. Computed tomography imaging of primary lung Cancer in mice using a liposomal-iodinated contrast agent. PloS one 2012 Apr 2, 7(4).
15. Zheng J., Allen C., Serra S., Vines D., Charron M., Jaffray D.A. Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology. Contrast Media Mol Imaging 2010, 5(3):147-154.
16. Li S., Goins B., Zhang L., Bao A. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. Bioconjugate Chem 2012 May 22, 23(6):1322-1332.
17. Portnoy E., Lecht S., Lazarovici P., Danino D., Magdassi S. Cetuximab-labeled liposomes containing near-infrared probe for invivo imaging. Nanomedicine : nanotechnology, biology. Medicine 2011 Aug, 7(4):480-488.
18. Proulx S.T., Luciani P., Derzsi S., Rinderknecht M., Mumprecht V., Leroux J.C., et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res 2010 Sep 15, 70(18):7053-7062.
19. Ntziachristos V., Razansky D. Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem Rev 2010, 110(5):2783-2794.
20. Zha Z., Deng Z., Li Y., Li C., Wang J., Wang S., et al. Biocompatible polypyrrole nanoparticles as a novel organic photoacoustic contrast agent for deep tissue imaging. Nanoscale 2013 May 21, 5(10):4462-4467.
21. Lovell J.F., Jin C.S., Huynh E., Jin H.L., Kim C., Rubinstein J.L., et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011 Apr, 10(4):324-332.
22. Ng K.K., Shakiba M., Huynh E., Weersink R.A., Roxin A., Wilson B.C., et al. Stimuli-responsive photoacoustic nanoswitch for invivo sensing applications. ACS nano 2014 Jul 28, 8(8):8363-8373.
23. Zhuang Y., Ma Y., Wang C., Hai L., Yan C., Zhang Y., et al. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: role of lymphatic trafficking and biodistribution. JControl Release 2012 Apr 10, 159(1):135-142.
24. Jeong H.S., Lee C.M., Cheong S.J., Kim E.M., Hwang H., Na K.S., et al. The effect of mannosylation of liposome-encapsulated indocyanine green on imaging of sentinel lymph node. JLiposome Res 2013 Dec, 23(4):291-297.
25. Buehler A., Herzog E., Razansky D., Ntziachristos V. Video rate optoacoustic tomography of mouse kidney perfusion. Opt Lett 2010 Jul 15, 35(14):2475-2477.
26. Buehler A., Rosenthal A., Jetzfellner T., Dima A., Razansky D., Ntziachristos V. Model-based optoacoustic inversions with incomplete projection data. MedPhys 2011 Mar, 38(3):1694-1704.
27. Rosenthal A., Razansky D., Ntziachristos V. Fast semi-analytical model-based acoustic inversion for quantitative optoacoustic tomography. IEEE Trans Med Imaging 2010 Jun, 29(6):1275-1285.
28. Razansky D., Distel M., Vinegoni C., Ma R., Perrimon N., Koster R.W., et al. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins invivo. Nat Photonics 2009 Jul, 3(7):412-417.
29. Ntziachristos V., Ripoll J., Wang L.V., Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 2005 Mar, 23(3):313-320.
30. Hong R.L., Huang C.J., Tseng Y.L., Pang V.F., Chen S.T., Liu J.J., et al. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clinical cancer research. official J Am Assoc Cancer Res 1999 Nov, 5(11):3645-3652.
31. Al-Jamal W.T., Al-Ahmady Z.S., Kostarelos K. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia. Biomaterials 2012 Jun, 33(18):4608-4617.
32. Herzog E., Taruttis A., Beziere N., Lutich A.A., Razansky D., Ntziachristos V. Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. Radiology 2012 May, 263(2):461-468.
33. Bao C., Beziere N., del Pino P., Pelaz B., Estrada G., Tian F., et al. Gold nanoprisms as optoacoustic signal nanoamplifiers for invivo bioimaging of gastrointestinal cancers. Small 2013 Jan 14, 9(1):68-74.
34. Lozano N., Al-Jamal W.T., Taruttis A., Beziere N., Burton N.C., Van den Bossche J., et al. Liposome-gold nanorod hybrids for high-resolution visualization deep in tissues. JAm Chem Soc 2012 Aug 15, 134(32):13256-13258.
35. Demers M., Ho-Tin-Noe B., Schatzberg D., Yang J.J., Wagner D.D. Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice. Cancer Res 2011 Mar 1, 71(5):1540-1549.
36. Fogh J., Fogh J.M., Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. JNatl Cancer Inst 1977 Jul, 59(1):221-226.
37. Kostarelos K. The long and short of carbon nanotube toxicity. Nat Biotechnol 2008 Jul, 26(7):774-776.
38. Simeonova P.P. Update on carbon nanotube toxicity. Nanomedicine (Lond) 2009 Jun, 4(4):373-375.
39. Zhang X.D., Wu D., Shen X., Liu P.X., Yang N., Zhao B., et al. Size-dependent invivo toxicity of PEG-coated gold nanoparticles. Int J nanomedicine 2011, 6:2071-2081.
40. Alander J.T., Kaartinen I., Laakso A., Patila T., Spillmann T., Tuchin V.V., et al. Areview of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012, 2012:940585.
41. Gathje J., Steuer R.R., Nicholes K.R. Stability studies on indocyanine green dye. JAppl Physiol 1970 Aug, 29(2):181-185.
42. Desmettre T., Devoisselle J.M., Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol 2000, 45(1):15-27.
43. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. JControl Release 2000, 65(1-2):271-284.
44. Buehler A., Kacprowicz M., Taruttis A., Ntziachristos V. Real-time handheld multispectral optoacoustic imaging. Opt Lett 2013 May 1, 38(9):1404-1406.
45. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4, 144(5):646-674.